The Claim
In female Wistar rats with D-galactose-induced accelerated aging and estrogen deprivation, spermidine treatment reduces cardiac mitochondrial reactive oxygen species and mitochondrial membrane depolarization to levels comparable to those achieved by estrogen therapy, indicating improved mitochondrial bioenergetic efficiency.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In female Wistar rats with accelerated aging and low estrogen, spermidine treatment lowers cardiac mitochondrial reactive oxygen species and stabilizes mitochondrial membrane potential to the same extent as estrogen therapy, resulting in improved mitochondrial energy production.
See the scientific wording
In female Wistar rats with D-galactose-induced accelerated aging and estrogen deprivation, spermidine treatment reduced cardiac mitochondrial reactive oxygen species and mitochondrial membrane depolarization to levels comparable to estrogen therapy, indicating improved mitochondrial bioenergetic efficiency.
Spermidine enters heart cells and stops excessive splitting of mitochondria, which reduces leakage of harmful molecules and stabilizes the energy-producing membrane. This lowers oxidative damage and fixes the cleanup process for damaged mitochondria, allowing the heart to produce energy more efficiently.
What the research says
1 studyIn aging rats without estrogen, spermidine helped their heart cells produce energy better by reducing harmful stress and fixing their energy factories—just like estrogen does. So spermidine might be a safe alternative to estrogen for heart health.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.